Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Aiach

Showing results (201-210 of 236) with videos related to

Pageof 24
Sort By:
Thrombosis and Haemostasis|December 18, 1987
Circulating activities during constant infusion of heparin or a low molecular weight derivative (enoxaparine): failure to demonstrate any circadian variationsP Toulon, J F Vitoux, C Leroy, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypassA Lillo-Le Louët, P Boutouyrie, M Alhenc-Gelas, et al.
British Journal of Clinical Pharmacology|December 1, 1995
Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteersM Azizi, C Veyssier-Belot, M Alhenc-Gelas, et al.
La Revue De Medecine Interne|September 1, 1984
[Intra-arterial thrombolysis with the combination of urokinase and lysyl-plasminogen. 27 cases of acute arterial obliteration of the lower limbs]J F Vitoux, J M Pernes, M Roncato, et al.
Thrombosis and Haemostasis|June 16, 1988
A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndromeS Gandrille, M H Jouvin, P Toulon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Thrombomodulin promoter mutations, venous thrombosis, and varicose veinsL Le Flem, L Mennen, M L Aubry, et al.
The Journal of Rheumatology|June 1, 1995
Primary antiphospholipid syndrome is not associated with activated protein C resistance caused by factor V Arg 506 -->Gln mutationV Biousse, J C Piette, C Frances, et al.
Thrombosis and Haemostasis|July 15, 2000
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic diseaseO Lozinguez, E Arnaud, L Belec, et al.
Annals of the Rheumatic Diseases|October 1, 1995
Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's diseaseP Lesprit, B Wechsler, J C Piette, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 14, 1973
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases]M Aiach, J Rogé, M F Busy, et al.
Pageof 24

Showing results (201-210 of 236) with videos related to

Sort By:
Pageof 24
Thrombosis and Haemostasis|December 18, 1987
Circulating activities during constant infusion of heparin or a low molecular weight derivative (enoxaparine): failure to demonstrate any circadian variationsP Toulon, J F Vitoux, C Leroy, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypassA Lillo-Le Louët, P Boutouyrie, M Alhenc-Gelas, et al.
British Journal of Clinical Pharmacology|December 1, 1995
Comparison of biological activities of two low molecular weight heparins in 10 healthy volunteersM Azizi, C Veyssier-Belot, M Alhenc-Gelas, et al.
La Revue De Medecine Interne|September 1, 1984
[Intra-arterial thrombolysis with the combination of urokinase and lysyl-plasminogen. 27 cases of acute arterial obliteration of the lower limbs]J F Vitoux, J M Pernes, M Roncato, et al.
Thrombosis and Haemostasis|June 16, 1988
A study of fibrinogen and fibrinolysis in 10 adults with nephrotic syndromeS Gandrille, M H Jouvin, P Toulon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Thrombomodulin promoter mutations, venous thrombosis, and varicose veinsL Le Flem, L Mennen, M L Aubry, et al.
The Journal of Rheumatology|June 1, 1995
Primary antiphospholipid syndrome is not associated with activated protein C resistance caused by factor V Arg 506 -->Gln mutationV Biousse, J C Piette, C Frances, et al.
Thrombosis and Haemostasis|July 15, 2000
Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic diseaseO Lozinguez, E Arnaud, L Belec, et al.
Annals of the Rheumatic Diseases|October 1, 1995
Activated protein C resistance caused by factor V Arg 506-->Gln mutation has no role in thrombotic manifestations of Behçet's diseaseP Lesprit, B Wechsler, J C Piette, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 14, 1973
[Acquired dysfibrinogenemia and hepatic disorders. Apropos of 30 cases]M Aiach, J Rogé, M F Busy, et al.
Pageof 24